Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Zaidi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood Advances|February 11, 2021
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infectionCaterina P Minniti, Ahmar U Zaidi, Mehdi Nouraie, et al.
Blood|January 30, 2025
Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic reviewLachelle D Weeks, Allecia M Wilson, Rakhi P Naik, et al.
NPJ Vaccines|January 6, 2024
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune responsePuthupparampil V Scaria, Nicole Roth, Kim Schwendt, et al.
NPJ Vaccines|July 18, 2019
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230Puthupparampil V Scaria, Christopher G Rowe, Beth B Chen, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood Advances|February 11, 2021
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infectionCaterina P Minniti, Ahmar U Zaidi, Mehdi Nouraie, et al.
Blood|January 30, 2025
Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic reviewLachelle D Weeks, Allecia M Wilson, Rakhi P Naik, et al.
NPJ Vaccines|January 6, 2024
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune responsePuthupparampil V Scaria, Nicole Roth, Kim Schwendt, et al.
NPJ Vaccines|July 18, 2019
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230Puthupparampil V Scaria, Christopher G Rowe, Beth B Chen, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Pageof 4